147 related articles for article (PubMed ID: 2918948)
21. Laminin in glomerular basement membranes of aminonucleoside nephrotic rats. Increased proteinuria induced by antilaminin immunoglobulin G.
Abrahamson DR; Hein A; Caulfield JP
Lab Invest; 1983 Jul; 49(1):38-47. PubMed ID: 6865329
[TBL] [Abstract][Full Text] [Related]
22. Synergy of monocytes and lymphocytes from idiopathic minimal lesion nephrotic patients in relapse in the production of the supernatant factor that increases rat glomerular basement membrane sulfate uptake.
Garin EH; Boggs KP
Int J Pediatr Nephrol; 1987; 8(4):187-92. PubMed ID: 3449467
[TBL] [Abstract][Full Text] [Related]
23. Elevated vascular endothelial growth factor levels in the urine of patients with minimal-change nephrotic syndrome.
Matsumoto K; Kanmatsuse K
Clin Nephrol; 2001 Apr; 55(4):269-74. PubMed ID: 11334311
[TBL] [Abstract][Full Text] [Related]
24. Gene expression profiling of peripheral blood mononuclear cells from patients with minimal change nephrotic syndrome by cDNA microarrays.
Komatsuda A; Wakui H; Iwamoto K; Harada M; Okumoto Y; Sawada K
Am J Nephrol; 2008; 28(4):539-47. PubMed ID: 18219197
[TBL] [Abstract][Full Text] [Related]
25. [Analysis of glomerular anionic charge status in renal biopsy specimens of childhood minimal change nephrotic syndrome using confocal laser scanning microscopy].
Sakagami Y; Nakajima M; Ueda T; Akazawa H; Maruhashi Y; Shimoyama H; Takagawa K; Kamitsuji H; Yoshioka A
Nihon Jinzo Gakkai Shi; 2000 Jan; 42(1):16-23. PubMed ID: 10737009
[TBL] [Abstract][Full Text] [Related]
26. Vascular permeability increasing factor (VPF) in IgA nephropathy.
Bakker WW; Beukhof JR; van Luijk WH; van der Hem GK
Clin Nephrol; 1982 Oct; 18(4):165-7. PubMed ID: 7140031
[TBL] [Abstract][Full Text] [Related]
27. Adult and paediatric patients with minimal change nephrotic syndrome show no major alterations in glomerular expression of sulphated heparan sulphate domains.
Wijnhoven TJ; Geelen JM; Bakker M; Lensen JF; Rops AL; Kramer AB; Navis G; van den Hoven MJ; van der Vlag J; Berden JH; Wetzels JF; van den Heuvel LP; Monnens LA; van Kuppevelt TH
Nephrol Dial Transplant; 2007 Oct; 22(10):2886-93. PubMed ID: 17526541
[TBL] [Abstract][Full Text] [Related]
28. Interleukin 12 upregulates the release of vascular permeability factor by peripheral blood mononuclear cells from patients with lipoid nephrosis.
Matsumoto K; Ohi H; Kanmatsuse K
Nephron; 1998; 78(4):403-9. PubMed ID: 9578066
[TBL] [Abstract][Full Text] [Related]
29. Increased interleukin-12 release from peripheral blood mononuclear cells in nephrotic phase of minimal change nephrotic syndrome.
Lin CY; Chien JW
Acta Paediatr Taiwan; 2004; 45(2):77-80. PubMed ID: 15335115
[TBL] [Abstract][Full Text] [Related]
30. Glomerular anionic sites in minimal change nephrotic syndrome and focal segmental glomerulosclerosis.
Kitano Y; Yoshikawa N; Nakamura H
Clin Nephrol; 1993 Oct; 40(4):199-204. PubMed ID: 8261675
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-4 cooperates with interleukin-10 to inhibit vascular permeability factor release by peripheral blood mononuclear cells from patients with minimal-change nephrotic syndrome.
Matsumoto K; Ohi H; Kanmatsuse K
Am J Nephrol; 1999; 19(1):21-7. PubMed ID: 10085445
[TBL] [Abstract][Full Text] [Related]
32. Effect of supernatants from nephrotic peripheral blood mononuclear cells on 35sulfate incorporation in rat glomerular basement membrane.
Garin EH; Boggs KP
Pediatr Res; 1985 Aug; 19(8):836-40. PubMed ID: 4034285
[TBL] [Abstract][Full Text] [Related]
33. The number of podocyte slit diaphragms is decreased in minimal change nephrotic syndrome.
Patrakka J; Lahdenkari AT; Koskimies O; Holmberg C; Wartiovaara J; Jalanko H
Pediatr Res; 2002 Sep; 52(3):349-55. PubMed ID: 12193666
[TBL] [Abstract][Full Text] [Related]
34. Significance of urinary fatty acid-binding protein 4 level as a possible biomarker for the identification of minimal change disease in patents with nephrotic-range proteinuria.
Tanaka M; Furuhashi M; Moniwa N; Maeda T; Takizawa H; Matsumoto M; Sakai A; Higashiura Y; Gocho Y; Koyama M; Ogawa Y; Miura T
BMC Nephrol; 2020 Nov; 21(1):459. PubMed ID: 33143633
[TBL] [Abstract][Full Text] [Related]
35. Effects of interleukin-15 on vascular permeability factor release by peripheral blood mononuclear cells in normal subjects and in patients with minimal-change nephrotic syndrome.
Matsumoto K; Ohi H; Kanmatsuse K
Nephron; 1999; 82(1):32-8. PubMed ID: 10224482
[TBL] [Abstract][Full Text] [Related]
36. Glomerular density-associated changes in clinicopathological features of minimal change nephrotic syndrome in adults.
Koike K; Tsuboi N; Utsunomiya Y; Kawamura T; Hosoya T
Am J Nephrol; 2011; 34(6):542-8. PubMed ID: 22123493
[TBL] [Abstract][Full Text] [Related]
37. Podocyte foot process effacement is not correlated with the level of proteinuria in human glomerulopathies.
van den Berg JG; van den Bergh Weerman MA; Assmann KJ; Weening JJ; Florquin S
Kidney Int; 2004 Nov; 66(5):1901-6. PubMed ID: 15496161
[TBL] [Abstract][Full Text] [Related]
38. A study of the plasma kinin-generating system in children with the minimal lesion, idiopathic nephrotic syndrome.
Kallen RJ; Lee SK
Pediatr Res; 1975 Sep; 9(9):705-9. PubMed ID: 53808
[TBL] [Abstract][Full Text] [Related]
39. Minimal change nephrotic syndrome developing during postoperative interferon-beta therapy for malignant melanoma.
Nakao K; Sugiyama H; Makino E; Matsuura H; Ohmoto A; Sugimoto T; Ichikawa H; Wada J; Yamasaki Y; Makino H
Nephron; 2002 Apr; 90(4):498-500. PubMed ID: 11961411
[TBL] [Abstract][Full Text] [Related]
40. [Changes in rat glomerular polyanion and ultrastructures induced by supernatants of cultured mononuclear cells from patients with steroid-response nephrotic syndrome].
Wang Z; Liu Z
Hua Xi Yi Ke Da Xue Xue Bao; 1995 Mar; 26(1):29-32. PubMed ID: 7657333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
